- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
- NSE15:44 | 21-01-2020
- BSE16:01 | 21-01-2020
Ind-Swift Ltd. Quarterly Results
Ind-Swift Ltd Share Price
Ind-Swift Ltd Risk Return Comparisonwith peersNew
Ind-Swift Ltd Financial Comparisonwith peers
Ind-Swift Ltd Share Holding as on 31-12-2019
|Category||No. of shares||Percentage|
About Ind-Swift Ltd.
Ind-Swift Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 17.12 Crore) operating in Pharmaceuticals sector.
Ind-Swift Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 266.24 Crore to Sales Value (98.39 % of Total Sales) and Other Operating Revenue which contributed Rs 4.33 Crore to Sales Value (1.60 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 30-09-2019, the company has reported a Standalone sales of Rs 82.62 Crore, up 22.13 % from last quarter Sales of Rs 67.65 Crore and up 13.70 % from last year same quarter Sales of Rs 72.66 Crore Company has reported net profit after tax of Rs .01 Crore in latest quarter.
The company’s top management includes Dr.Gopal Munjal, Dr.Jatender Kumar Kakkar, Dr.V K Arora, Dr.V R Mehta, Mr.Himanshu Jain, Mr.Jagvir Singh Ahluwalia, Mr.N R Munjal, Mr.Rishav Mehta, Mr.S C Galhotra, Mr.S P Sharma, Mr.S R Mehta, Ms.Anoop Michra. Company has Jain & Associates as its auditoRs As on 31-12-2019, the company has a total of 54,164,653 shares outstanding.